AltMountain

Alpha Ascent Organelle LLC

Philadelphia, PA · CIK 1954420
Status: no Form D since Dec 2022. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Alpha Ascent Organelle LLC is a venture capital fund based in Philadelphia, Pennsylvania. According to its most recent Form D, filed Dec 15, 2022, it has sold $2,000,000 of interests to 17 investors since its first sale in Dec 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Alpha Ascent Ventures LLC; Eric Greenberg; Alpha Ascent Organelle Manager LLC.

Total raised
$2,000,000Cumulative sales reported on Form D
Investors
17
First sale
Dec 13, 2022
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Alpha Ascent Ventures LLC; Eric Greenberg; Alpha Ascent Organelle Manager LLC
Latest Form D
Dec 15, 2022

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌‌⁠

Questions about Alpha Ascent Organelle LLC

What is the minimum investment for Alpha Ascent Organelle LLC?

Alpha Ascent Organelle LLC's latest Form D, filed Dec 15, 2022, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Alpha Ascent Organelle LLC?

Alpha Ascent Organelle LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Alpha Ascent Organelle LLC raised?

Alpha Ascent Organelle LLC reports $2,000,000 sold from 17 investors on its Form D filed Dec 15, 2022. This is cumulative sales since the offering began, not current assets or performance.

Where is Alpha Ascent Organelle LLC based?

Alpha Ascent Organelle LLC is based in Philadelphia, Pennsylvania.

When did Alpha Ascent Organelle LLC launch?

Alpha Ascent Organelle LLC reports its first sale in Dec 2022.

Size compared with every venture capital fund

Raised more than 62% of the 76 venture capital funds based in Pennsylvania, and more than 70% of all 14,901 that report sales.

Other funds with the same team

More venture capital funds in Philadelphia

Similar-size venture capital funds in Pennsylvania

All venture capital funds in Pennsylvania